Canada
From psilocybin mushroom cultivators to artists and Indigenous leaders, the conference united a broad range of people
Hi, what are you looking for?
Mugglehead Investment Magazine
Psychedelics
Canada
Trial will evaluate the efficacy of synthetic psilocybin drug 'APEX-52' for treating vets with PTSD
International
The companies say this will be the 'world's first' in-clinic application of VR with psychedelic-assisted therapy
Psychedelics
New phase I study will be held at MAC Clinical Research in Manchester, England next year
Canada
11th annual conference will feature prominent speakers and artists including Dennis McKenna, Vanessa Le-Fan Yuen and Paul Stamets joining virtually from Florida
Psychedelics
Algernon will provide cGMP DMT for the study in exchange for part-ownership of IP generated
Psychedelics
The company has enhanced its IP portfolio with a patent that will be valid until 2041
International
The market researcher anticipates a 14.5% CAGR during the 2021-2026 forecast period
International
The new member organization consists of over 78,000 psychiatrists
Canada
New amendment to the Mental Health Services Protection Regulation has been initiated to effectively safeguard patients
